GoodRx Releases Second Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
GoodRx Holdings, Inc. (GDRX) Misses Q2 EPS by 4c, Offers Guidance
August 8, 2022 4:23 PM EDTGoodRx Holdings, Inc. (NASDAQ: GDRX) reported Q2 EPS of $0.00, $0.04 worse than the analyst estimate of $0.04. Revenue for the quarter came in at $191.8 million versus the consensus estimate of $185.36 million.
GUIDANCE:
GoodRx Holdings, Inc. sees Q3 2022 revenue of $185 million, versus the... More
